EP3079721A4 - Compositions pharmaceutiques à base de caroténoïde - Google Patents

Compositions pharmaceutiques à base de caroténoïde Download PDF

Info

Publication number
EP3079721A4
EP3079721A4 EP14870207.9A EP14870207A EP3079721A4 EP 3079721 A4 EP3079721 A4 EP 3079721A4 EP 14870207 A EP14870207 A EP 14870207A EP 3079721 A4 EP3079721 A4 EP 3079721A4
Authority
EP
European Patent Office
Prior art keywords
carotenoid
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP14870207.9A
Other languages
German (de)
English (en)
Other versions
EP3079721B1 (fr
EP3079721A1 (fr
Inventor
Fu Feng Kuo
Bin-huei CHEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health-Ever Biotech Co Ltd
Original Assignee
Health-Ever Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health-Ever Biotech Co Ltd filed Critical Health-Ever Biotech Co Ltd
Publication of EP3079721A1 publication Critical patent/EP3079721A1/fr
Publication of EP3079721A4 publication Critical patent/EP3079721A4/fr
Application granted granted Critical
Publication of EP3079721B1 publication Critical patent/EP3079721B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L15/00—Egg products; Preparation or treatment thereof
    • A23L15/30—Addition of substances other than those covered by A23L15/20 – A23L15/25
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Birds (AREA)
  • Pediatric Medicine (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP14870207.9A 2013-12-11 2014-12-09 Compositions pharmaceutiques à base de caroténoïde Active EP3079721B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361914879P 2013-12-11 2013-12-11
PCT/IB2014/066737 WO2015087242A1 (fr) 2013-12-11 2014-12-09 Compositions pharmaceutiques à base de caroténoïde

Publications (3)

Publication Number Publication Date
EP3079721A1 EP3079721A1 (fr) 2016-10-19
EP3079721A4 true EP3079721A4 (fr) 2017-07-19
EP3079721B1 EP3079721B1 (fr) 2024-04-10

Family

ID=53370695

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14870207.9A Active EP3079721B1 (fr) 2013-12-11 2014-12-09 Compositions pharmaceutiques à base de caroténoïde

Country Status (15)

Country Link
US (2) US9603811B2 (fr)
EP (1) EP3079721B1 (fr)
JP (2) JP6166480B2 (fr)
KR (2) KR101786532B1 (fr)
CN (3) CN110200917B (fr)
CA (1) CA2933086C (fr)
HK (1) HK1223018A1 (fr)
IL (1) IL246142B (fr)
MY (1) MY164822A (fr)
PH (1) PH12016501117B1 (fr)
RU (1) RU2649124C2 (fr)
SA (1) SA516371303B1 (fr)
SG (1) SG10201702500RA (fr)
TW (3) TWI721386B (fr)
WO (1) WO2015087242A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110200917B (zh) * 2013-12-11 2021-09-21 健永生技股份有限公司 类胡萝卜素的医药组合物
GB201618350D0 (en) * 2016-10-31 2016-12-14 Ip Science Ltd Methods and compositions comprising carotenoids
CN108537025B (zh) * 2018-03-29 2020-08-18 Oppo广东移动通信有限公司 隐私保护方法和装置、计算机可读存储介质、终端
JP2021097615A (ja) * 2019-12-20 2021-07-01 エア・ウォーター物流株式会社 加工飼料

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080044475A1 (en) * 2006-08-18 2008-02-21 Industrial Organica S.A. De C.V. Absorption and bioavailability of carotenoids, formulations and applications
CN101991175A (zh) * 2010-10-09 2011-03-30 江南大学 一种高顺式异构体含量的番茄红素微乳制剂产品及制备方法
EP2468111A1 (fr) * 2010-12-21 2012-06-27 Jose-Odon Torres-Quiroga Compositions et applications de caroténoïdes à absorption améliorée et biodisponibilité

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6030652B2 (ja) * 1979-05-07 1985-07-17 株式会社ミドリ十字 静脈注射用脂肪乳剤
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
JPH06157298A (ja) * 1992-11-26 1994-06-03 Otsuka Pharmaceut Co Ltd 注射用脂肪乳剤
JPH09157159A (ja) * 1995-12-11 1997-06-17 Lion Corp カロチノイド含有組成物
DE19609476A1 (de) * 1996-03-11 1997-09-18 Basf Ag Stabile zur parenteralen Verabreichung geeignete Carotinoid-Emulsionen
AUPO693397A0 (en) * 1997-05-22 1997-06-12 Betatene Limited Carotenoid formulation
US6075058A (en) 1998-12-12 2000-06-13 Tufts University Compositions for increased bioavailability of carotenoids
US7758893B2 (en) * 2001-07-27 2010-07-20 N.V. Nutricia Enteral compositions for the prevention and/or treatment of sepsis
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
US20070082044A1 (en) * 2004-03-10 2007-04-12 Trustees Of Tufts College Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene
TWI288614B (en) 2004-11-12 2007-10-21 Panatoz Corp Lycopene compound
CN100488535C (zh) * 2004-12-09 2009-05-20 郭富凤 一种番茄红素混合物
CN1853620A (zh) * 2005-04-29 2006-11-01 诺氏制药（吉林）有限公司 鱼腥草素类似物的脂肪乳剂
TW200738227A (en) 2006-04-03 2007-10-16 Panatoz Corp One kind of multi-carotenoids and its administration
CN100998573A (zh) * 2006-06-26 2007-07-18 宁波健永生物科技有限公司 多重茄红素调合制备的胶囊的功效及用途
CN101112359B (zh) * 2007-07-31 2010-09-15 中国农业大学 一种透明水分散型β-胡萝卜素浓缩液的制备方法
JP2009189335A (ja) * 2008-02-18 2009-08-27 Sanei Gen Ffi Inc カロテノイド色素含有乳化組成物及びその製造方法
PT2519230T (pt) * 2009-12-31 2019-01-18 Marius Pharmaceuticals Llc Modulação de solubilidade, estabilidade, absorção, metabolismo e perfil farmacocinético de fármacos lipofílicos por esteróis
CN102552173B (zh) * 2010-12-23 2014-01-29 浙江医药股份有限公司新昌制药厂 一种高生物利用度的类胡萝卜素油悬浮液及其制备方法
GB201101669D0 (en) * 2011-01-31 2011-03-16 Ip Science Ltd Carotenoid particles and uses thereof
US20130004619A1 (en) * 2011-06-28 2013-01-03 Kemin Industries, Inc. Method of Forming Encapsulated Compositions with Enhanced Solubility and Stability
CN103732078A (zh) 2011-08-11 2014-04-16 帝斯曼知识产权资产管理有限公司 用于透明的以及对巴氏灭菌稳定的液体制剂特别是饮料的包含类胡萝卜素的乳剂
GB201120772D0 (en) * 2011-12-02 2012-01-11 Ip Science Ltd Cocoa-based food products
GB201121519D0 (en) * 2011-12-14 2012-01-25 Ip Science Ltd Fat-based food products
CN102525923B (zh) * 2012-02-16 2014-09-10 中国农业大学 类胡萝卜素乳液及微胶囊的制备方法
CN110200917B (zh) * 2013-12-11 2021-09-21 健永生技股份有限公司 类胡萝卜素的医药组合物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080044475A1 (en) * 2006-08-18 2008-02-21 Industrial Organica S.A. De C.V. Absorption and bioavailability of carotenoids, formulations and applications
CN101991175A (zh) * 2010-10-09 2011-03-30 江南大学 一种高顺式异构体含量的番茄红素微乳制剂产品及制备方法
EP2468111A1 (fr) * 2010-12-21 2012-06-27 Jose-Odon Torres-Quiroga Compositions et applications de caroténoïdes à absorption améliorée et biodisponibilité

Also Published As

Publication number Publication date
PH12016501117A1 (en) 2016-08-15
RU2649124C2 (ru) 2018-03-29
TW201622704A (zh) 2016-07-01
JP2017501996A (ja) 2017-01-19
KR101699426B1 (ko) 2017-01-24
CN107260675A (zh) 2017-10-20
TW201932102A (zh) 2019-08-16
TW201524534A (zh) 2015-07-01
WO2015087242A1 (fr) 2015-06-18
CN105682684A (zh) 2016-06-15
US20160051470A1 (en) 2016-02-25
CA2933086A1 (fr) 2015-06-18
KR101786532B1 (ko) 2017-10-18
JP2017160266A (ja) 2017-09-14
SG10201702500RA (en) 2017-05-30
EP3079721B1 (fr) 2024-04-10
US9539219B2 (en) 2017-01-10
KR20160149315A (ko) 2016-12-27
CN110200917A (zh) 2019-09-06
IL246142B (en) 2019-03-31
US20160271076A1 (en) 2016-09-22
MY164822A (en) 2018-01-30
TWI531386B (zh) 2016-05-01
US9603811B2 (en) 2017-03-28
JP6166480B2 (ja) 2017-07-19
PH12016501117B1 (en) 2016-08-15
EP3079721A1 (fr) 2016-10-19
CA2933086C (fr) 2019-04-02
SA516371303B1 (ar) 2018-09-16
IL246142A0 (en) 2016-07-31
TWI671084B (zh) 2019-09-11
TWI721386B (zh) 2021-03-11
HK1223018A1 (zh) 2017-07-21
KR20160048209A (ko) 2016-05-03
CN110200917B (zh) 2021-09-21
CN107260675B (zh) 2018-12-18

Similar Documents

Publication Publication Date Title
EP3052487A4 (fr) Compositions d'éfinaconazole stabilisée
EP3055414A4 (fr) Compositions pour moduler l'expression de c90rf72
EP3082817A4 (fr) Compositions pour administration de médicaments
EP3021843A4 (fr) Composés anti-viraux, compositions pharmaceutiques et méthodes d'utilisation correspondantes
EP2968214A4 (fr) Nouvelles compositions analgésiques
EP3016667A4 (fr) Compositions orales
EP3020778A4 (fr) Composition adhésive
EP3085385A4 (fr) Composition pharmaceutique contenant de l'adalimumab
EP3038465A4 (fr) Formulation pharmaceutique orale d'omarigliptine
EP3089982A4 (fr) Analogues 7-bêta d'orvinols
EP3041511A4 (fr) Compositions d'eltrombopag
EP2990039A4 (fr) Composition pharmaceutique solide
EP3055281A4 (fr) Préparation de dérivés d'hydroxy-benzylbenzène
EP3064513A4 (fr) Composition contenant un polyrotaxane
EP2991618B8 (fr) Composition stable ä une dose élevée contenant levoleucovorine
EP3049079A4 (fr) Formes solides de ceftolozane
EP3003324A4 (fr) Compositions pharmaceutiques
EP3075822A4 (fr) Composition de parfum
EP3080080A4 (fr) Nouvelles compositions
EP3065729A4 (fr) Nouvelles formulations
EP3009497A4 (fr) Composition nettoyante
EP3033392A4 (fr) Composition mécano-réactive
HK1223018A1 (zh) 類胡蘿蔔素的醫藥組合物
EP3063152A4 (fr) Préparation pratique de morphinan-6-ols n-substitués à partir de morphinan-6-ones
EP3177297A4 (fr) Compositions liées à la vitamine d

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160512

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/127 20060101ALI20170608BHEP

Ipc: A61K 47/44 20170101ALI20170608BHEP

Ipc: A61K 47/14 20170101ALI20170608BHEP

Ipc: A61K 47/24 20060101ALI20170608BHEP

Ipc: A61K 47/26 20060101ALI20170608BHEP

Ipc: A61K 47/22 20060101ALI20170608BHEP

Ipc: A61K 9/107 20060101ALI20170608BHEP

Ipc: A61K 31/015 20060101AFI20170608BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20170619

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200813

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0047280000

Ipc: A61K0045060000

Ref country code: DE

Ref legal event code: R079

Ref document number: 602014089927

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61K0047280000

Ipc: A61K0045060000

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/00 20060101ALI20230926BHEP

Ipc: A23K 20/179 20160101ALI20230926BHEP

Ipc: A23K 20/147 20160101ALI20230926BHEP

Ipc: A61K 47/26 20060101ALI20230926BHEP

Ipc: A23K 20/158 20160101ALI20230926BHEP

Ipc: A61K 31/7032 20060101ALI20230926BHEP

Ipc: A61K 31/685 20060101ALI20230926BHEP

Ipc: A61K 31/575 20060101ALI20230926BHEP

Ipc: A61K 31/355 20060101ALI20230926BHEP

Ipc: A61K 31/01 20060101ALI20230926BHEP

Ipc: A61K 47/44 20060101ALI20230926BHEP

Ipc: A61K 9/107 20060101ALI20230926BHEP

Ipc: A61K 47/24 20060101ALI20230926BHEP

Ipc: A61K 47/14 20060101ALI20230926BHEP

Ipc: A61K 45/06 20060101AFI20230926BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20231103

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014089927

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D